Subtype
Ureter Neoplasm
CI-CAN-00004175Explore in graph →
Non-malignant19 active trials1 evidence items
Loading cancer entity…
Subtype
CI-CAN-00004175Explore in graph →
Clinical trials
71 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03935347 | Adoptive Cell Therapy With (LN-145) in Combination With Pembrolizumab in Treating Patients With Unresectable or Metastatic Transitional Cell Cancer Who Have Failed Cisplatin-Based Chemotherapy | withdrawn | Phase 2 | 0 | Roswell Park Cancer InstituteOTHER | 1 | Jan 2, 2020 | clinicaltrials |
| NCT01639521 | Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer | withdrawn | Phase 2 | 0 | University of Southern CaliforniaOTHER |
| 0 |
| Jan 29, 2014 |
| clinicaltrials |
Data updated 22 days agoSource updated Jan 2, 2020source: clinicaltrials